诺华 Novartis
诺华集团致力于为患者及社会提供创新医药健康解决方案,以满足其日益变化的健康需求。总部位于瑞士巴塞尔,诺华集团拥有多元化业务组合以最好地满足这些需求,包含创新药、成本节约型非专利药和生物类似药以及眼科保健产品。诺华在上述各领域均处于全球领先地位。2017年,集团净销售额达491亿美元,集团研发投入约为90亿美元。诺华集团拥有近12.5万名全职员工。诺华的产品在全球155个国家和地区销售。
Add to FavoritesComply with the latest international and domestic standards, and cooperate with the pharmacovigilance system to improve the efficiency of pharmacovigilance work
Provides solutions for drug safety in the clinical trial phase, and supports the electronic direct reporting CDE center
Have international/domestic senior pharmacovigilance experts to help enterprises quickly establish a pharmacovigilance system
Assist customers in developing and hosting call centers, WeChat, app, websites and other channels to collect drug adverse events
Service personnel with many years of clinical and pharmacovigilance experience can conduct medical coding, medical examination and other case processing services.
Assist in writing FDAAR, DSUR, PSUR and other drug warning reports
Artificial intelligence assists with signal detection and assists customers in developing risk management plans, risk minimization measures, etc.
We can help pharmaceuticals transforming past paper data to electronic, structured and standardized data.
Pharmacovigilance doctor with extensive clinical experience provides professional medical review services for pharmaceutical companies
诺华集团致力于为患者及社会提供创新医药健康解决方案,以满足其日益变化的健康需求。总部位于瑞士巴塞尔,诺华集团拥有多元化业务组合以最好地满足这些需求,包含创新药、成本节约型非专利药和生物类似药以及眼科保健产品。诺华在上述各领域均处于全球领先地位。2017年,集团净销售额达491亿美元,集团研发投入约为90亿美元。诺华集团拥有近12.5万名全职员工。诺华的产品在全球155个国家和地区销售。
Add to Favorites